| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 43,934 | 45,367 | 50,579 | 50,579 | | Cost of Revenue | 14,543 | 15,819 | 18,638 | 19,332 | | | Gross Profit | 29,391 | 29,548 | 31,941 | 31,247 | | | Operating Expenses | | Research Development | 9,297 | 11,620 | 8,889 | 8,406 | | Selling General and Administrative | 19,703 | 18,652 | 18,790 | 18,868 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 391 | (724) | 4,262 | 3,973 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 444 | 441 | 181 | 809 | | Earnings Before Interest And Taxes | 835 | (283) | 4,443 | 4,782 | | Interest Expense | 25 | 25 | 24 | 16 | | Income Before Tax | 810 | (308) | 4,419 | 4,766 | | Income Tax Expense | 80 | (71) | (18,363) | 1,302 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 730 | (237) | 22,782 | 3,464 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 730 | (237) | 22,782 | 3,464 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $730 | ($237) | $22,782 | $3,464 |
|
0.22% Nasdaq 
Income Statement
